Trade MREO anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Mereo BioPharma Group plc American Depositary Shares (MREO) is trading at US$0.25, down 8.16% today as of Sep 4, 16:00 EDT. The company has a market capitalisation of US$46.37M. Over the past 52 weeks, MREO has traded between US$0.20 and US$2.37. On Syfe you can trade MREO with $0 commission and add it to your watchlist.
| Previous close | US$0.27 |
|---|---|
| Market cap | US$46.37M |
| 52-week range | US$0.20 – US$2.37 |
| Volume | 1.32M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Mereo BioPharma Group plc American Depositary Shares
Mereo BioPharma Group Plc is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that aim to improve outcomes for oncology and rare diseases. Its portfolio include Etigilimab (MPH-313), Alvelestat (MPH-966), Setrusumab (BPS-804), Navicixizumab (OMP-305B83), Acumapimod (BCT-197), and Leflutrozole (BGS-649). The company was founded by Denise Vera Scots-Knight, Charles Edward Sermon, Alastair Graham MacKinnon, and John P. Richard in March 10, 2015 and is headquartered in London, the United Kingdom.
Year: 2018
--JPMorgan Downgrades Mereo BioPharma to Neutral From Overweight
Mar 23, 11:43 AM · MT Newswires
Stay on top of MREO
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
